News | July 25, 2011

Philips Installs 100th EP Cockpit at Indiana Hospital

July 25, 2011 — Memorial Hospital of South Bend, Ind., installed the 100th Philips interventional X-ray system with electrophysiology (EP) cockpit XL. The system includes an Allura Xper FD 10, EP cockpit workflow solution and EP navigator cardiac visualization tool.

When considering a new EP lab at Memorial Hospital, one concept was top of mind: bringing together information from multiple sources to help physicians deal with the challenges of information overload. The combination product features FlexVision, a 56-inch monitor capable of displaying up to eight different inputs at one time along with design choices to help create a fluid, intuitive and efficient working environment. With Philips, for example, a ceiling-mounted equipment rack provides a single location for third-party equipment like mapping, recording and a stimulator.

“EP labs are traditionally cluttered with lots of technology and lots of monitors,” said Raman Mitra, M.D., Ph.D., medical director, Leighton Heart and Vascular Center, Memorial Hospital. “The EP cockpit XL is streamlined and allows for fully customized viewing of all images on one large monitor in the exam room. The control room is also more streamlined with options such as keyboard and video switching.”

“While our cockpit marks a milestone for Philips’ success, it’s hitting high marks with Memorial Hospital by supporting our ability to provide excellent care to patients,” said Sean Halleran, M.D., medical director of electrophysiology lab, Memorial Hospital.

The package at Memorial Hospital also includes Philips’ EP navigator, which gives clinicians a comprehensive view of where they are in the heart, in real time. A 3-D volume can be overlaid directly on top of live fluoroscopy images and this enhanced display can be helpful in determining where a catheter or lead is positioned in relation to other anatomical structures during navigation.

For more information: www.healthcare.philips.com

Related Content

Abbott Secures FDA Approval for MRI Compatibility on Ellipse ICD
Technology | Implantable Cardioverter Defibrillator (ICD)| September 22, 2017
Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Technavio Projects 9 Percent Global Growth for Electrophysiology Therapeutic Devices

Image courtesy of Technavio

News | EP Lab| September 11, 2017
September 11, 2017 — According to the latest market study released by Technavio, the global...
Siemens Healthineers Receives FDA Clearance for TrueFusion Structural Heart Disease Feature
Technology | Cardiovascular Ultrasound| September 06, 2017
The U.S. Food and Drug Administration (FDA) has cleared TrueFusion, a new cardiovascular application from Siemens...
EMANATE Trial Shows Apixaban Lowers stroke in AF Patients Undergoing Cardioversion.
News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naïve patients with at
CASTLE-AF Study shows Catheter Ablation of Atrial Fibrillation is First-Line Treatment for Heart Failure Patients. Biotronic Ilivia 7 ICD.

The CASTLE-AF Study shows catheter alation of AF can be used effectively to treat heart failure in patients with an implanted ICD.

News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Final results from the CASTLE-AF study show a 38 percent reduction in the composite of all-cause
Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices

Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices.

Feature | EP Lab| August 29, 2017 | Dave Fornell
August 29, 2017 — The U.S.
Overlay Init